Table 1.

Patient demographics

Patient	Sex	Age	Diagnosis	Eligibility Mutation	Prior Lines of Therapy	Prior Platinum
1	F	69	Uterine Sarcoma	BRCA2 g3237delCA	5	Y
2	F	59	Ovarian	BRCA1 gR1751X (5379C > T)	9	Y
3	F	65	Ovarian	BRCA1 g187delAG	8	Y
4	M	73	Prostate	BRCA2 gK1872X (5842A > T)	1	N
5	M	61	Prostate	BRCA1 g Q1756fs*74	6	N
6	F	52	Breast	BRCA1 g2576delC	7	Y
7	M	61	Prostate	BRCA2 g c.476-2A > G	1	N
8	F	33	Breast	BRCA2 g3917delC	4	N
9	M	73	Pancreatic	BRCA1 g3171ins5	1	Y